The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

The launch of a new version of the Clinical Trials Information System (CTIS) is giving earlier and more efficient access to clinical trial information in Europe. Revised transparency rules eliminate deferral mechanisms providing public access to approximately 4000 clinical trials.The revised transparency rules were adopted by EMA’s Management Board in October 2023 following a public consultation held between May and June 2023. Read more about the revised CTIS tranparency rules here:

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70